Spread the love

  • A study from the Department of Clinical and Molecular Cardiovascular ResearchKeio University School of Medicine, Shinjuku-ku Tokyo, Japan;  and Department of Cardiology, Keio University School of Medicine, Shinjuku-ku Tokyo, Japan;  and  JST CREST, Shinjuku-ku Tokyo, Japan has reported that “MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing …

  • This study was published in the June 2014 issue of EMBO Journal by Prof. Ieda M, Muraoka N and others from the Department of Clinical and Molecular Cardiovascular Research, Keio University School of Medicine, Shinjuku-ku Tokyo, Japan Department of Cardiology, Keio University School of Medicine, Shinjuku-ku Tokyo, Japan.
  • On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that:Therapeutic insights into making the highly efficient cardiomyocyte-like cells from differentiated cells: Reversine inhibits cardiac reprogramming by increasing Snai expression. This study suggests that Reversine, by increasing the expression of its target gene, it could decrease the number of beating cardiomyocyte-like cells (iCMs).

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,Therapeutic insights into making the highly efficient cardiomyocyte-like cells from differentiated cells: Reversine inhibits cardiac reprogramming by increasing Snai expression, 22/October/2014, 20.19,  Genome-2-Bio-Medicine Discovery center (GBMD)http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation


Spread the love